FDA Grants Fast Track Designation to Balstilimab/Zalifrelimab Combination for Cervical Cancer

The FDA granted fast track designation to balstilimab and zalifrelimab based on comprehensive data found to support their potential as a combination therapy.

Younger Cancer Survivors See Higher Burden of Financial Worry and Food Insecurity

Given these findings, researchers highlighted the need for interventions and policy efforts that address reducing food insecurity and financial worry among cancer survivors.

New Genetic Structural Variants Identified in Childhood Leukemias

Previously unrecognized genetic structural variants in childhood leukemias could be used to evaluate the presence of minimal residual disease during chemotherapy and help to determine response to various therapies.